(Q28574297)

English

cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects

scientific journal article

In more languages

Statements

scholarly article

1 reference

31 January 2017

cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects (English)

1 reference

31 January 2017

0 references

author name string

S. Sondhi

1

1 reference

31 January 2017

J. M. Castellano

2

1 reference

31 January 2017

V. Z. Chong

3

1 reference

31 January 2017

R. M. Rogoza

4

1 reference

31 January 2017

K. J. Skoblenick

5

1 reference

31 January 2017

B. A. Dyck

6

1 reference

31 January 2017

J. Gabriele

7

1 reference

31 January 2017

N. Thomas

8

1 reference

31 January 2017

K. Ki

9

1 reference

31 January 2017

Z. B. Pristupa

10

1 reference

31 January 2017

A. N. Singh

11

1 reference

31 January 2017

D. MacCrimmon

12

1 reference

31 January 2017

P. Voruganti

13

1 reference

31 January 2017

J. Foster

14

1 reference

31 January 2017

R. K. Mishra

15

1 reference

31 January 2017

publication date

1 March 2006

1 reference

31 January 2017

The Pharmacogenomics Journal

1 reference

31 January 2017

6

1 reference

31 January 2017

131–140

1 reference

31 January 2017

2

1 reference

31 January 2017

Upregulation of glucose-dependent insulinotropic polypeptide and its receptor in the retina of streptozotocin-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Prospects for pharmacotherapy of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Clozapine: efficacy and safety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

The effect of clozapine on glucose metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

A prospective study of impairment in glucose control caused by clozapine without changes in insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Aripiprazole: initial clinical experience with 142 hospitalized psychiatric patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Gastric inhibitory polypeptide (GIP) binding sites in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

The incretin concept today

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Dietary regulation of glucose-dependent insulinotropic peptide (GIP) gene expression in rat small intestine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Gastric inhibitory polypeptide: the neglected incretin revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

The metabolic role of GIP: physiology and pathology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

GIP biology and fat metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Electronimmunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) im man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Glucose dependent insulinotropic polypeptide (GIP) infused intravenously is insulinotropic in the fasting state in type 2 (non-insulin dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Hypersecretion of Gastric Inhibitory Polypeptide Following Oral Glucose in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Elevated plasma glucose-dependent insulinotropic polypeptide associates with hyperinsulinemia in impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Adrenergic modulation of gastric inhibitory polypeptide secretion in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Molecular pharmacology of alpha 2-adrenoceptor subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Immunohistochemical localization of a 40-kDa catecholamine regulated protein in the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Gastric Inhibitory Polypeptide: Structure and Chromosomal Localization of the Human Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Two 3',5'-cyclic-adenosine monophosphate response elements in the promoter region of the human gastric inhibitory polypeptide gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

21 January 2018

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Clozapine and associated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel antipsychotics and new onset diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric inhibitory polypeptide (GIP) stimulation by oral glucose in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastric Inhibitory Polypeptide: Its Physiologic Release and Insulinotropic Action in the Dog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500346

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.TPJ.6500346

1 reference

31 January 2017

Dimensions Publication ID

0 references

1 reference

31 January 2017

ResearchGate publication ID

0 references

Springer Nature article ID

10.1038/sj.tpj.6500346

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28574297&oldid=1834315650"